Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B H Arison

Showing results (71-80 of 83) with videos related to

Pageof 9
Sort By:
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 1, 1980
Identification of a glutathione conjugate of cambendazole formed in the presence of liver microsomesD E Wolf, J A VandenHeuvel, T R Tyler, et al.
Journal of Medicinal Chemistry|November 1, 1980
Urinary metabolites of timolol from humans and laboratory animals. Syntheses and beta-adrenergic blocking activitiesB K Wasson, J Scheigetz, C S Rooney, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 1, 1988
Metabolism of kadsurenone and 9,10-dihydrokadsurenone in rhesus monkeys and rat liver microsomesK L Thompson, M N Chang, J C Chabala, et al.
International Journal of Peptide and Protein Research|February 1, 1984
Synthesis and conformational study of a cyclic hexapeptide analog of somatostatin containing dehydrophenylalanineS F Brady, D W Cochran, R F Nutt, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 1, 1992
Metabolism of a new HIV-1 reverse transcriptase inhibitor, 3-[2-(benzoxazol-2-yl)ethyl]-5-ethyl-6-methylpyridin-2(1H)-one (L-696,229), in rat and liver slicesS K Balani, S M Pitzenberger, L R Kauffman, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 1, 1994
Metabolism of 3-[2-(benzoxazol-2-yl)ethyl]-5-ethyl-6-methylpyridin-2 (1H)-one (L-696,229), an HIV-1 reverse transcriptase inhibitor, by rat liver slices and in humansS K Balani, L R Kauffman, B H Arison, et al.
The Journal of Organic Chemistry|January 15, 1971
The synthesis of peptides in aqueous medium. VII. The preparation and use of 2,5-thiazolidinediones in peptide synthesisR S Dewey, E F Schoenewaldt, H Joshua, et al.
Nature|July 2, 1981
A potent cyclic hexapeptide analogue of somatostatinD F Veber, R M Freidlinger, D S Perlow, et al.
Journal of Agricultural and Food Chemistry|November 1, 1978
Urinary metabolites of cambendazoleW J VandenHeuvel, D E Wolf, B H Arison, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 19, 2000
Metabolites of caspofungin acetate, a potent antifungal agent, in human plasma and urineS K Balani, X Xu, B H Arison, et al.
Pageof 9

Showing results (71-80 of 83) with videos related to

Sort By:
Pageof 9
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 1, 1980
Identification of a glutathione conjugate of cambendazole formed in the presence of liver microsomesD E Wolf, J A VandenHeuvel, T R Tyler, et al.
Journal of Medicinal Chemistry|November 1, 1980
Urinary metabolites of timolol from humans and laboratory animals. Syntheses and beta-adrenergic blocking activitiesB K Wasson, J Scheigetz, C S Rooney, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 1, 1988
Metabolism of kadsurenone and 9,10-dihydrokadsurenone in rhesus monkeys and rat liver microsomesK L Thompson, M N Chang, J C Chabala, et al.
International Journal of Peptide and Protein Research|February 1, 1984
Synthesis and conformational study of a cyclic hexapeptide analog of somatostatin containing dehydrophenylalanineS F Brady, D W Cochran, R F Nutt, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 1, 1992
Metabolism of a new HIV-1 reverse transcriptase inhibitor, 3-[2-(benzoxazol-2-yl)ethyl]-5-ethyl-6-methylpyridin-2(1H)-one (L-696,229), in rat and liver slicesS K Balani, S M Pitzenberger, L R Kauffman, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 1, 1994
Metabolism of 3-[2-(benzoxazol-2-yl)ethyl]-5-ethyl-6-methylpyridin-2 (1H)-one (L-696,229), an HIV-1 reverse transcriptase inhibitor, by rat liver slices and in humansS K Balani, L R Kauffman, B H Arison, et al.
The Journal of Organic Chemistry|January 15, 1971
The synthesis of peptides in aqueous medium. VII. The preparation and use of 2,5-thiazolidinediones in peptide synthesisR S Dewey, E F Schoenewaldt, H Joshua, et al.
Nature|July 2, 1981
A potent cyclic hexapeptide analogue of somatostatinD F Veber, R M Freidlinger, D S Perlow, et al.
Journal of Agricultural and Food Chemistry|November 1, 1978
Urinary metabolites of cambendazoleW J VandenHeuvel, D E Wolf, B H Arison, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 19, 2000
Metabolites of caspofungin acetate, a potent antifungal agent, in human plasma and urineS K Balani, X Xu, B H Arison, et al.
Pageof 9